Skip to main content
BactiQuant A/S logo

BactiQuant A/S — Investor Relations & Filings

Ticker · BACTIQ ISIN · DK0061417730 LEI · 9845000O0B4DFC4BF748 ST Professional, scientific and technical activities
Open in API
Filings indexed 24 across all filing types
Latest filing 2026-03-18 Annual Report
Country DK Denmark
Listing ST BACTIQ

About BactiQuant A/S

https://bactiquant.com/

BactiQuant A/S develops and provides patented technology for the rapid monitoring and quantification of bacterial contamination levels in water. The company's solutions facilitate both mobile and continuous online surveillance of the total bacterial load, delivering near real-time results. This capability allows for proactive water management across various industries such as public water utilities, pharmaceuticals, manufacturing, and aquaculture. The technology is applicable to all water types, enabling clients to optimize the use of biocides, prevent biofouling and corrosion, extend asset lifespans, and improve overall water safety.

Recent filings

Filing Released Lang Actions
Årsregnskab 2025: Vækst på 16% og solid likviditet sikrer godt grundlag for øget vækst.
Annual Report Classification · 100% confidence The document is titled 'ÅRSRAPPORT' (Annual Report) for BactiQuant A/S for the fiscal year 2025. It contains comprehensive financial statements, including the income statement, balance sheet, cash flow statement, management review, and the independent auditor's report. It is clearly the full annual report rather than an announcement or summary. FY 2025
2026-03-18 Danish
Årsregnskab 2025: Vækst på 16% og solid likviditet sikrer godt grundlag for øget vækst.
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2606 characters) from BactiQuant A/S regarding the publication of their 2025 Annual Report. It provides a summary of key financial highlights and explicitly states 'Der henvises i øvrigt til den vedhæftede årsrapport' (Reference is also made to the attached annual report) and includes a link to download the PDF. Following the 'Menu vs Meal' rule, this is an announcement of a report rather than the full report itself, making it a Report Publication Announcement (RPA).
2026-03-18 Danish
Guidance for 2026 viser en forventet vækst i omsætning på mellem 20% og 50%
Regulatory Filings Classification · 95% confidence The document is a short announcement (under 5,000 characters) issued by BactiQuant A/S regarding their financial guidance for 2026. It provides key highlights of expected revenue and EBITDA but does not constitute a full financial report. It includes a link to download the full announcement as a PDF, which aligns with the 'Report Publication Announcement' (RPA) category as per the 'Menu vs Meal' rule.
2026-02-04 Danish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is titled 'Storaktionærmeddelelse' (Major shareholder announcement) and explicitly states that a shareholder (Muragasan Claes Nielsen) has crossed the 5% ownership threshold. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2025-11-20 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document is a notification of transactions made by persons discharging managerial responsibilities (PDMR) in the company BactiQuant A/S. It references compliance with the EU Market Abuse Regulation (MAR) and reports insider transactions related to share dealings. The document includes details about the transaction and mentions attachments with further information. The content is focused on insider share transactions by company directors or executives, which fits the definition of Director's Dealing filings. The document length is short and it is not a full financial report or announcement of a report publication, so it is not classified as RPA or other report types.
2025-11-20 English
Director's Dealing 2025
Director's Dealing Classification · 95% confidence The document is a detailed table reporting transactions executed by persons with managerial responsibilities or closely related persons. It includes information about the person, the issuer, the financial instrument, transaction type, price, quantity, and transaction date. The content matches the characteristics of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document is not an announcement of a report, nor does it contain financial statements or management commentary. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 2435 characters, which is consistent with a detailed insider transaction report rather than a full financial report or announcement.
2025-11-20 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.